EDAP TMS S.A. (FOCL)
NASDAQ: FOCL · Real-Time Price · USD
5.10
+0.05 (0.99%)
At close: Jun 26, 2026, 4:00 PM EDT
5.15
+0.05 (0.98%)
After-hours: Jun 26, 2026, 4:04 PM EDT
EDAP TMS Earnings Call Transcripts
Fiscal Year 2026
-
FocalTherics is accelerating growth as a robotic focal therapy leader, leveraging proprietary HIFU technology and expanding into new indications like BPH and endometriosis. Strong clinical evidence, favorable reimbursement, and global adoption support a pathway to profitability by 2028.
-
The company is executing a strategic shift to focus on high-growth robotic focal therapy, with HIFU now driving over 60% of revenue and robust clinical evidence supporting rapid adoption. Expansion into BPH and endometriosis, advanced imaging, AI, and telecollaboration underpin a scalable platform targeting 40%+ annual growth and 60% gross margins by 2028.